Henglong Hu

8PUBLICATIONS
26CO-AUTHORS
Biomedical imagingMolecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Inorganic materials (incl. nanomaterials)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 29, 2023
Evaluation of Whole-Tumor Texture Analysis Based on MRI Diffusion Kurtosis and Biparametric VI-RADS Model for Staging and Grading Bladder Cancer.

Xiaoyan Meng, Shichao Li, Kangwen He

|Dec 11, 2022
Oncolytic Viruses for the Treatment of Bladder Cancer: Advances, Challenges, and Prospects.

Henglong Hu, Qidong Xia, Jia Hu

|Nov 25, 2022
Statin Use Is Associated with Better Prognosis of Patients with Prostate Cancer after Definite Therapies: A Systematic Review and Meta-Analysis of Cohort Studies.

Ye An, Jian-Xuan Sun, Meng-Yao Xu

|Sep 09, 2022
A Systematic Review on the Role of Repeat Transurethral Resection after Initial en Bloc Resection for Non-Muscle Invasive Bladder Cancer.

Henglong Hu, Mengqi Zhou, Binrui Yang

|Aug 16, 2021
Proteomic analysis reveals some common proteins in the kidney stone matrix.

Yuanyuan Yang, Senyuan Hong, Cong Li

|Dec 12, 2019
Management of recurrent ureteral stricture: a retrospectively comparative study with robot-assisted laparoscopic surgery versus open approach.

Qing Wang, Yuchao Lu, Henglong Hu

Pageof 2

Frequent Collaborators

3 joint publications

Shaogang Wang

3 joint publications

Jiaqiao Zhang

2 joint publications

Cong Li

2 joint publications

Yufeng Wang